Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.53 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.53 |
| ▸ | GABRP | O00591 | 1/20 | 0.53 |
| ▸ | GABRD | O14764 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.53 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.53 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.53 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.53 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.53 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL301894 | 1.00 | — | — | |
| Acetic Acid SCHEMBL9807766 | 1.00 | CYP1A2 (0.53) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL9116471 | 1.00 | CYP1A2 (0.53) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL4397846 | 1.00 | CYP1A2 (0.53) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL10590830 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL10590828 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL29029757 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL9615722 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL28975705 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM | |
| Acetic Acid SCHEMBL7634596 | 0.97 | PAOX (0.50) | CYP1A2GABRR1LMNATHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1021 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250222110-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS | LIVIONEX INC (US) | 2025-07-10 | — | — | US | claimed |
| US-20240382597-A1 | FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER | LIVIONEX INC (US) | 2024-11-21 | — | — | US | claimed |
| CN-114426490-B | Catalytic hydrogenation method of unsaturated compound | 中国石油化工股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-116082646-B | Dynamic cross-linked polyether amide elastomer and preparation method thereof | 万华化学集团股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20240158941-A1 | Gold Plating Bath and Gold Plated Final Finish | MACDERMID ENTHONE INC. | 2024-05-16 | — | — | US | claimed |
| CN-117964495-A | Method for synthesizing 3-aminophenylacetylene | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117924028-A | Process for preparing 1, 4-butenediol from 1, 4-butynediol | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117804860-A | Sample stabilizer of hyaluronic acid chemiluminescence detection kit, preparation method of sample stabilizer and hyaluronic acid detection kit | 深圳市科曼医疗设备有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117673425-A | Electrolyte of iron-chromium flow battery and preparation method thereof | 斯瑞尔环境科技股份有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117645652-A | Cyclic peptides, methods for their preparation, complexes comprising them, and their use | 核欣(苏州)医药科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| EP-0538970-A2 | Corrosion inhibition with water-soluble rare earth chelates | W.R. Grace & Co.-Conn. (US) | 1993-04-28 | — | — | EP | claimed |
| US-5130052-A | Rare earth metal chelates for corrosion resistance | W. R. GRACE & CO.-CONN. (US) | 1992-07-14 | — | — | US | claimed |
| US-5030658-A | For plant protection; sodium or potassium salts of oleic acid, linoleic acid and 12-20 carbon fatty acids; alkali metal or alkanolamine salt of carboxylic acids or alkylenepolyamine polyacidic acids as chelating agent | SAFER, INC. (US) | 1991-07-09 | — | — | US | claimed |
| EP-0301477-B1 | SILVER HALIDE COLOR PHOTOSENSITIVE MATERIAL AND METHOD OF PROCESSING THEREOF | Fuji Photo Film Co., Ltd. (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0301477-A2 | Silver halide color photosensitive material and method of processing thereof | Fuji Photo Film Co., Ltd. (JP) | 1989-02-01 | — | — | EP | claimed |
| EP-0272218-A2 | Method of preparing a hologram | ILFORD Limited (GB) | 1988-06-22 | — | — | EP | claimed |
| US-4452643-A | CONTACTING WITH OXIDIZING AGENT AND CITRIC ACID AND OXALIC ACID AND SALTS | HALLIBURTON COMPANY (US) | 1984-06-05 | — | — | US | claimed |
| US-4278646-A | Oxidative removal of hydrogen sulfide from gaseous streams | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1981-07-14 | — | — | US | claimed |
| US-3988223-A | Unplugging of electrolysis diaphragms | BASF WYANDOTTE CORPORATION (US) | 1976-10-26 | — | — | US | claimed |
| US-3942984-A | Process for bleach-fixing chromogenically color photographic silver halide material | AGFA-GEVAERT AKTIENGESELLSCHAFT (DT) | 1976-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222110-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS | MSMO1, SLC16A8, SMS | CYP1A2 3432/4885GABRR1 3534/4885LMNA 3443/4885 |
| US-20240382597-A1 | FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER | TNF, CD14, CXCL8 | CYP1A2 892/4885GABRR1 2961/4885LMNA 2944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.